Rehabilitation Needs of the Malaysian Haematological Cancer Survivors

Completed

• Conditions: Haematological Malignancy; Quality of Life; Lymphoma; Blood Cancer; Leukemia, Acute; Myeloma Multiple
• Interventions: Other: WHODAS 2.0 Questionnaire

• Registration Number: NCT04236063
• Lead Sponsor: University of Malaya

Brief Summary

Many cancers are being treated more effectively nowadays due to the raised awareness and early detection as well as advancement in researches and technology. Despite the rising number of cancer survivors in the coming years, these survivors are still plagued by the poor quality of life due to physical and psychological impairment. According to the National Cancer Registry Report from 2007-2011, haematological cancer is one of the ten most common cancers in Malaysian population. Many haematological cancer survivors in Malaysia are reportedly having poor quality of life due to multiple physical and emotional impairments which leads to further disability in life. It is thus an important effort to identify the rehabilitation needs in these cancer survivors to implement alternatives to improve the disease outcome through cancer rehabilitation.

Detailed Description

A cross-sectional questionnaire-based study will be employed to identify the rehabilitation needs and predictors of needs in outpatient hemato-oncological cohort at UMMC Hemato-oncology Clinic for 12 months. The validated questionnaire employed evaluates the potential disabilities that could affect the aforementioned patients in domains such as communication, independence in mobility, self-care, social participation, handling relationships and domestic activity of daily living a month prior to the survey.

Participants of age between 18 to 80 years old, diagnosed with haemato-oncological illnesses will be screened; excluding potential participants who are too ill or cannot understand English, Malay, or Chinese; to be recruited in the research.

Based on the findings from the analysis, rehabilitation needs could be tailored accordingly to improve quality of life of these patients

Study Timeline

• Study Start: 2019-07-15
• Study First Submitted: 2019-09-23
• Study First Submitted QC: 2020-01-19
• Study First Posted: 2020-01-22
• Primary Completion: 2020-03-31
• Study Completion: 2020-05-31
• Status Verified: 2020-11
• Last Update Submitted: 2020-11-02
• Last Update Posted: 2020-11-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 168

Inclusion Criteria

• patient with haematological malignancy
• agreeable to participate in the interview

Exclusion Criteria

• ill at the time of follow up
• unable to understand English, Malay or Chinese
• refuse to be interviewed

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Haematological malignancy	WHODAS 2.0 Questionnaire	Patients with haematological malignancy

Primary Outcome Measures

Name	Time	Method
World Health Organization Disability Assessment Schedule (WHODAS) 2.0	30 days ago from interview date	WHODAS 2.0 is a practical, generic assessment tool that measures health and disability at population level or in clinical practice. It identifies possible disabilities in 6 domains of life namely Cognitive, Mobility, Self Care, Relationship, Life Activities and Participation. In view of its resemblance to the International Classification of Functioning, Disability and Health (ICF) model, direct identification of functioning and disability separately from the disease condition could be done.; Each domain has few sets of questions pertaining to the activities; the responses and scores of each question are divided into none (0), mild (1), moderate (2), severe (3) and extremely cannot do (4). The scores from each domain will be summed and higher scores signifies higher disability status.

Secondary Outcome Measures

Name	Time	Method
Identifying patients who are at risk of disability from haemato-oncological illness	30 days ago from interview date	Disability outcomes of different groups of patients (of demographics and diagnosis) were analyzed using SPSS program and identification of patients who were vulnerable to haematological cancers were done using ANOVA test.

Trial Locations

Locations (1)

University Malaya; 🇲🇾 Kuala Lumpur, Wilayah Persekutuan, Malaysia